Successful packaging of aseptically prefilled products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Successful packaging of aseptically prefilled products


Pharmaceutical Technology Europe
Volume 21, Issue 9

Why is accurate packaging and process calibration such an essential component of a successful aseptically prefilled injection system?


Paul Nelles
Properly calibrating a drug with its packaging is one of today's most critical processes in providing high-quality aseptic filling solutions. Increasingly complex drug molecules are making more and more demands on the composition of injection systems while regulatory authorities worldwide are also tightening safety laws. To complicate the situation further, drug manufacturers and users alike are calling for more patient-friendly application systems.

Many of these demands cannot be satisfied without packaging solutions that are perfectly calibrated to the specific needs of the substances involved. These solutions will allow an aseptically prefilled product to remain stable in the injection system until it is administered.

Many substances are sensitive to the materials and components used for packaging, and substances can often interact with rubber stoppers, closure systems and other related components in ways that will unintentionally alter the product's parameters and performance characteristics.

Production processes also influence the active substance, which means packaging materials and pharmaceutical processes must also be perfectly calibrated with the active substance. Failing to correctly calibrate packaging and processes can significantly alter the effectiveness (and the outcome) of any aseptic filling solution.

To be successful, how should the packaging and calibration process for aseptically prefilled products be structured?

To ensure all packaging and required processes are harmonized, a number of steps must be taken — none can be overlooked without risking a less than acceptable outcome. Below is a brief overview of the most critical steps.

• Approach packaging and associated filling processes as a whole, rather than separately.

With development times for drugs averaging up to 10 years, costing hundreds of millions of euro and requiring countless complicated processes, packaging and filling concerns are often approached in isolation. This can be a serious mistake because harmonizing packaging and filling processes from the very beginning is one of the best ways of minimizing unforeseen problems later on. Your project team should always include experts in both packaging and filling who work closely together in all phases of strategic planning, process development and production to minimize risks at either end.

• Make a clear assessment of a drug substance's specific features and relevant interactive properties.

Examining a substance's specific features and determining how they interact with all the other components is a critical element of success. For example, silicone is a material commonly used to lubricate stoppers and glass containers prior to insertion into the syringe; however, silicone has been associated with protein inactivation. Certain solutions may also be sensitive to light or moisture, which can alter the specific features of a product. Unless a clear assessment is made of how substances and components will react to each other, your desired outcomes can be seriously compromised.

• Develop efficient and effective production processes early.

The need for efficient and effective production processes may seem an obvious requirement, but developing production efficiency can often be inadvertently overlooked, especially if production processes are not considered until the very last stages of a product's launch. As an example, to maximize efficiency and minimize unnecessary costs, processes needed for filling must be individually evaluated and developed for every product separately. In fact, regardless of the product in question, a number of steps must be carefully evaluated and calibrated to ensure maximum efficiency. Thawing procedures, handling, mixing and filtration, for example, must all be taken into consideration.

Other issues include: "What type of tubing will be used?" "What is the maximum filtration pressure allowed?" "Has the filling been checked against the type of pumping system being used?" Answering such questions prior to production and ensuring these procedures are in place helps create a more efficient, manageable and profitable production process.

Simulate production conditions in the laboratory.

One of the best ways to achieve the results you want is to simulate production conditions in a laboratory before the actual manufacturing process begins. This not only allows you to develop and test production processes in a real-world scenario, but provides a cost-effective way to identify and correct potential errors prior to the manufacturing stage of the product launch.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology Europe,
Click here